Company intelligence / Profile preview

Research Institute for Liver Diseases

Shanghai, Shanghai, Chinapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Other

Overview

No specific clinical results publicly available. The institute is known as a contract research organization supporting preclinical and clinical studies in liver disease.

Therapeutic areas: GastroenterologyOncologyInfectious Diseases
Modalities: Small moleculeBiologic (inferred based on typical liver disease research focus; not explicitly stated)
Industry: Contract Research Organization

Partnerships

Not publicly listed; likely collaborates with pharmaceutical companies requiring CRO services in China.

Beyond the preview

Go deeper on Research Institute for Liver Diseases.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Research Institute for Liver Diseases.

Explore the full profile